Equine Rhinopneumonitis Vaccine

Killed Virus

For intramuscular vaccination of healthy horses 9 months of age or older as an aid in the prevention of respiratory diseases caused by the EHV 1p and EHV 1b viruses as well as for use in pregnant mares as an aid in the prevention of abortion due to EHV 1 infections.

DOSAGE AND ADMINISTRATION:
For pregnant mares, aseptically administer one 2 mL dose intramuscularly during the 5th, 7th and 9th months of pregnancy. Revaccinate annually at the 5th, 7th and 9th months of pregnancy.

For young horses, aseptically administer one 2 mL dose intramuscularly followed by a second 2 mL dose 3 to 4 weeks later. Revaccinate with a single 2 mL dose 6 months after the second primary dose and annually thereafter. To insure proper placement and retention of the vaccine, inject deep into the heavy muscles of the hindquarter. Mild exercise to promote absorption is recommended for one week after injection.

CAUTION: Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE VIGOROUSLY to assure uniform suspension of the vaccine. Use entire contents when first opened (20 mL). When used according to instructions, local or systemic reactions rarely occur. An occasional local swelling or induration at the site of injection may be encountered. Do not vaccinate within 60 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.